ISTH/LinkedIn
Oct 3, 2025, 12:30
ISTH: Advancing Hemophilia Treatment Today and Tomorrow
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
“New CME opportunity! The hemophilia treatment landscape is rapidly evolving — are you up to date?
Our latest expert-led module, Updates in FVIIa Mimetics: Advancing Hemophilia Treatment Today and Tomorrow, is designed for hematology care teams including physicians, NPs, PAs, nurses and pharmacists.
What you’ll get:
- Key insights into emerging therapies
- Clinical trial updates
- Best practices to individualize patient care”
Start learning today here
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 16:05Alisha Tuck: Navigating the First Trimester – Ultrasound and Anticoagulation Management
-
Apr 15, 2026, 15:59Filippo Cademartiri: Plaque Burden Is the Dominant Determinant of Long-Term Coronary Risk Beyond Stenosis
-
Apr 15, 2026, 15:33Peter Zdziarski: Will Glanzmann Thrombasthenia Patients Be Formally Recognized as Benefiting from SevenFACT?
-
Apr 15, 2026, 15:20Sonal Sonu: Blood Donation Myths in Rural Areas
-
Apr 15, 2026, 15:01Augustina Isioma Ikusemoro: The Most Misunderstood Cause of a Prolonged APTT in the Laboratory
-
Apr 15, 2026, 14:55Donald Correll: Key Risk Factors for Venous Thromboembolism
-
Apr 15, 2026, 14:48Fadwa Said Abdelazim: Is Vaping Really ‘Safer’ for the Blood Than Smoking?
-
Apr 15, 2026, 14:42Augustina Isioma Ikusemoro: An Underrecognized Cause of Severe Thrombocytopenia Following Transfusion
-
Apr 15, 2026, 14:42Caitlin Raymond: Augmented Intelligence Enhancing Human Capability Without Replacement